Transcend Capital Advisors’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,383	Closed	-$249K	–	668
2025 Q1	$249K	Buy	1,383 +1	+0.1%	+$180	0.02%	515
2024 Q4	$217K	Hold	1,382	–	–	0.02%	523
2024 Q3	$252K	Buy	+1,382	New	+$252K	0.02%	516